FIELD: chemistry.
SUBSTANCE: invention relates to pyrrolo[2,1-f][1,2,4]triazine compound of general formula I, its isomer, pharmaceutically acceptable salt, ester or hydrate. Compound of general formula I possess properties of PI3K kinase activity. In general formula I X is CH or N; R1 is -NR5R6; R2 is ; R3 is -NH2, -NHC(O)NHR11, -NHC(O)OR11, -NHC(O)R11, -CH2OH, -CH2S(O)2R12 or -CH2NHS(O)2R12; R4 is H or CF3. Invention also relates to a method of producing pyrrolo[2,1-f][1,2,4]triazine compounds of general formula I and use thereof in preparing drugs for treating a disease associated with phosphatidylinositol 3-kinase and inhibitor of rapamycin target protein.
EFFECT: technical result is obtaining novel pyrrolo[2,1-f][1,2,4] triazine compound of general formula I, having PI3K kinase activity inhibitor properties.
11 cl, 2 dwg, 5 tbl, 39 ex
Title | Year | Author | Number |
---|---|---|---|
2-ARYLBENZOFURANE-7-FORMAMIDE COMPOUNDS, METHOD FOR OBTAINING AND APPLICATION THEREOF | 2013 |
|
RU2583900C2 |
FGFR INHIBITOR AND ITS MEDICAL USE | 2018 |
|
RU2771311C2 |
COMPOUNDS BASED ON 7-SUBSTITUTED PYRROLOTRIAZINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHODS FOR THEIR PREPARATION AND APPLICATION | 2018 |
|
RU2745548C1 |
HYDROXYPURINE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2685417C1 |
S1P1 AGONIST AND ITS APPLICATION | 2017 |
|
RU2754845C2 |
PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS AN MTOR/PI3K INHIBITOR | 2015 |
|
RU2658912C1 |
NAPHTHYLAMIDE COMPOUND, PREPARATION METHOD AND USE THEREOF | 2015 |
|
RU2655607C2 |
SYNTHESIS AND ANTICANCER ACTIVITY OF DERIVATIVES OF ARYL AND HETEROARYL QUINOLINES | 2011 |
|
RU2584688C2 |
QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 |
|
RU2695815C2 |
PHENYL [A]INDOLE [2,3-G] QUINOLYSINS, THEIR PREPARATION METHOD, COMPOSITIONS CONTAINING THEM AND APPLICATION OPTIONS | 2017 |
|
RU2756197C2 |
Authors
Dates
2016-07-10—Published
2013-04-23—Filed